Ethoxyindole-based CFB inhibitor for complement-mediated diseases

DISEASE CATEGORY: Renal; hematology; autoimmune disease

INDICATION: Renal; nephropathy; paroxysmal nocturnal hemoglobinuria (PNH); arthritis

In vitro, cell culture, mouse and rat studies identified an

Read the full 227 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE